Description

4-(1,1-Dioxido-1,2-thiazinan-2-yl)-2-[(4-phenyl-1-piperazinyl)sulfonyl]phenyl methyl ether is a high-purity, synthetically derived organic compound of significant interest in advanced chemical research and development. Its complex molecular architecture, featuring a sulfonyl-linked phenylpiperazine moiety fused with a thiazinane dioxide ring, makes it a valuable intermediate for creating novel pharmacologically active molecules. This compound is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of new chemical entities (NCEs) for therapeutic applications.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used as a key scaffold or precursor for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• Chemical Biology Probe: Employed in the development of tool compounds for investigating specific biological pathways and protein targets.
• Fine Chemical Synthesis: Acts as a specialized intermediate for the production of complex, high-value organic molecules in custom synthesis projects.
• Reference Standard: Supplied as a high-purity analytical standard for quality control and method development in analytical laboratories.

Basic Information

Product Name	4-(1,1-Dioxido-1,2-thiazinan-2-yl)-2-[(4-phenyl-1-piperazinyl)sulfonyl]phenyl methyl ether
CAS No.	919971-85-0
Molecular Formula	C21H25N3O4S2
Molecular Weight	447.57 g/mol
Synonyms	4-(1,1-Dioxido-1,2-thiazinan-2-yl)-2-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl methyl ether; 2-[(4-Phenyl-1-piperazinyl)sulfonyl]-4-(1,1-dioxido-1,2-thiazinan-2-yl)phenyl methyl ether; Methyl 4-(1,1-dioxido-1,2-thiazinan-2-yl)-2-[(4-phenylpiperazin-1-yl)sulfonyl]phenyl ether; 919971-85-0; 4-(1,1-Dioxido-1,2-thiazinan-2-yl)-2-[(4-phenyl-1-piperazinyl)sulfonyl]anisole
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality protocols to ensure batch-to-batch consistency and reliability for critical research applications. All material is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We employ state-of-the-art analytical techniques, including HPLC, NMR, and mass spectrometry, to verify chemical structure and confirm high purity levels suitable for pharmaceutical R&D. Specifications are designed to meet the exacting requirements of medicinal chemistry and process development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (typically 15-25°C). The compound should be kept under an inert atmosphere if long-term storage is required to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.